Sr One Capital Management, Llc bought $10.0M of Avalyn Pharma (AVLN)

Executed May 1, disclosed May 1, the same day.

Value, as filed

$10.0M

555,555 sh across 2 lots

Executed

May 1

the trade date, as filed

Disclosed

May 1

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-4.8%

-4.8% from execution

Over the 21 trading sessions from the disclosed entry session (May 1), the stock returned -4.8% (delay-adjusted); from the execution session (May 1), -4.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

SL Sr One Capital Management, Llc 10% owner profile →

Sr One Capital Management, Llc (10% owner) filed 3 Form 4 reports as a reporting entity in the trailing twelve months (3 purchases, 0 sales), most often in AVLN. Across 3 priced purchase filings, the average 21-session return was +7.4% from execution and +11.3% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of ODTX (555,555 sh across 3 lots, as filed), executed May 11.

The name

AVLN AVLN AVLN · 3 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→